New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis

Published:2015-04 Issue:4 Volume:37 Page:691-715
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

English Clayton,Aloi Joseph J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference84 articles.

1. Merritt’s Neurology.;Rowland,2010

2. Multiple sclerosis;Compston;Lancet,2008

3. Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States;Kobelt;Neurology,2006

4. Managed care aspects of managing multiple sclerosis;Mathis;Am J Manag Care,2013

5. Improving quality of life in multiple sclerosis: an unmet need;Zwibel;Am J Manag Care,2011

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Nanoparticles for Skin Protection — A Review;Nano LIFE;2024-08-09

2. A Review for Uncovering the “Protein-Nanoparticle Alliance”: Implications of the Protein Corona for Biomedical Applications;Nanomaterials;2024-05-08

3. Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis;Brain Research;2024-01

4. Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives;Journal of Pharmaceutical Sciences;2023-11

5. Assessing treatment switch among patients with multiple sclerosis: A machine learning approach;Exploratory Research in Clinical and Social Pharmacy;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP